Changes during storage indicate problems
Cytotoxic concentrations of alpha-defensins in the lungs of individuals with alpha-1 antitrypsin deficiency and moderate to severe lung disease
With a substantial body of Phase 3 data now published, the picture that emerges is one of genuine clinical promise, complicated by a competitive landscape that has raised the bar considerably
However, identifying responsive tumor subpopulations remains a major obstacle in developing metabolism-targeted therapies, as metabolic vulnerabilities vary among cancers with different oncogene expression profiles
Clinical data shows improvements in sleep quality, faster sleep onset, and more REM at 50 to 300mg daily
Furthermore, glycocholic acid, glycodeoxycholic acid, and taurocholic acid (TCA) were detected as biomarkers in NBC and BCA (Liu et al., 2015)